Creating a Tissue Bank of Knee Capsules
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
A contracture is a pathological condition limiting range and function of joints. Contractures of large and small joints alike will affect one's ability to independently perform daily activities such as eating, dressing or walking. Current treatments for contractures include physical stretching, the use of assistive devices or, rarely, surgery. Despite prolonged treatments, patients with contractures rarely regain complete mobility. Progress in preventing and treating contractures will be possible only through an understanding of the biological and molecular processes involved. Our group has established and validated an animal model to study the histological events and the molecular mechanisms involved in joint contractures. We have provided evidence for capsule stiffness, characterized cartilage degeneration, and identified four genes whose expression is altered in the cartilage of a knee joint with contracture. The work we propose in the current study aims at finding genes and pathways in the joint capsule associated with knee joint contractures. The results will identify new avenues for treating the large number of patients suffering from contractures.
| Condition |
|---|
|
Osteoarthritis Knee Joint Contractures |
| Study Type: | Observational |
| Study Design: | Observational Model: Cohort Time Perspective: Retrospective |
| Official Title: | Knee Joint Contractures: Reversibility and Molecular Pathways |
- development of contracture post total knee arthroplasty [ Time Frame: Within 1 year ] [ Designated as safety issue: No ]1.3% of subjects are expected to develop a contracture post toal knee arthroplasty within a year of the surgery.
Biospecimen Retention: Samples With DNA
A blood sample will be drawn from each subject and stored with the capsule tissue.
| Estimated Enrollment: | 1500 |
| Study Start Date: | March 2011 |
| Estimated Study Completion Date: | December 2014 |
| Estimated Primary Completion Date: | August 2014 (Final data collection date for primary outcome measure) |
| Groups/Cohorts |
|---|
|
osteoarthritis, total knee arthroplasty
The main cohort will have a total knee arthroplasty and will not develop a contracture post surgery. We will analyze differntial gene expression in all subjects.
|
|
contracture post arthroplasty
A small group (1.3%) will develop a contracture post total knee arthroplasty. A second sample will be taken at the time of corrective surgery. The 2 samples will be compared for gene expression in the same subject. This group will also be compared to the main cohort for differential gene expression.
|
Detailed Description:
We propose to constitute a bank of capsule samples from people with osteoarthritis undergoing primary total knee arthroplasty. It is expected that about 1.3% of people will develop a contracture post arthroplasty. A second sample will be taken from those that require surgery for release of contracture or revision. We will study histological characteristics and compare gene expression between the primary sample and the contracture sample in the same patient. In order to determine whether intrinsic genetic factors influence the develpment of joint contractures in the osteoarthritis population, all specimens will be analyzed for differential gene expression between patients with and without knee contractures post arthroplasty.
The remaining capsule tissue not used for this study will be banked and made available to other researchers.
Eligibility| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
| Sampling Method: | Probability Sample |
All patients booked for a total knee arthroplasty at the Ottawa Hospital, with a primary diagnosis of osteoarthritis.
Inclusion Criteria:
- Osteoarthritis, booked for a total knee arthroplasty
Exclusion Criteria:
- Transmissible disease (e.g., HIV infection, hepatitis B or C)
- Suspected neoplasia
- Suspected infection (which can cause arthrofibrosis)
- Hypertrophic scarring
Contacts and Locations| Contact: Elizabeth Coletta, RN | (613)737-7350 ext 75691 | ecoletta@ottawahospital.on.ca |
| Contact: Guy Trudel, MD | (613)737-7350 ext 75591 | gtrudel@ottawahospital.on.ca |
| Canada, Ontario | |
| The Ottawa Hospital | Recruiting |
| Ottawa, Ontario, Canada, K1H 8M2 | |
| Principal Investigator: Odette Laneuville, PhD | |
| Principal Investigator: Guy Trudel, MD | |
| Sub-Investigator: Hans K Uhthoff, MD | |
| Principal Investigator: | Guy Trudel, MD | University of Ottawa |
More Information
No publications provided
| Responsible Party: | Dr. Guy Trudel, University of Ottawa |
| ClinicalTrials.gov Identifier: | NCT01320124 History of Changes |
| Other Study ID Numbers: | 2010930-01H |
| Study First Received: | March 18, 2011 |
| Last Updated: | May 11, 2011 |
| Health Authority: | Canada: Ethics Review Committee |
Keywords provided by Ottawa Hospital Research Institute:
|
Contractures Total knee arthroplasty Tissue bank Osteoarthritis Gene expressions |
Additional relevant MeSH terms:
|
Contracture Osteoarthritis Joint Diseases Musculoskeletal Diseases |
Muscular Diseases Arthritis Rheumatic Diseases |
ClinicalTrials.gov processed this record on May 23, 2013